| Early childhood otitis media and later school performance–A prospective cohort study of associations V Fougner, A Kørvel-Hanquist, A Koch, J Dammeyer, J Niclasen, J Lous, ... International Journal of Pediatric Otorhinolaryngology 94, 87-94, 2017 | 22 | 2017 |
| Implementing targeted therapies in the treatment of glioblastoma: previous shortcomings, future promises, and a multimodal strategy recommendation V Fougner, B Hasselbalch, U Lassen, J Weischenfeldt, HS Poulsen, ... Neuro-Oncology Advances 4 (1), vdac157, 2022 | 9 | 2022 |
| GLIOTARGET: A DANISH NATIONWIDE PHASE I/II PLATFORM TRIAL FOCUSING ON INDIVIDUALIZED TARGETED TREATMENT FOR NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS BASED ON GENOMIC PROFILING V Fougner, B Hasselbalch, T Urup, U Lassen, H Poulsen Neuro-Oncology 23, 193-193, 2021 | 2 | 2021 |
| Actionable alterations in glioblastoma: insights from the implementation of genomic profiling as the standard of care from 2016 to 2023 V Fougner, T Urup, HS Poulsen, K Grunnet, CY Westmose, LC Melchior, ... Neuro-Oncology Practice 12 (1), 34-44, 2025 | 1 | 2025 |
| The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients DS Nørøxe, S Maarup, V Fougner, A Muhic, S Møller, T Urup, MJS Lü, ... Neuro-Oncology Advances 5 (1), vdad137, 2023 | 1 | 2023 |
| IDENTIFYING TARGETABLE ALTERATIONS PREDICTIVE OF DISTANT PROGRESSION IN GLIOBLASTOMA PATIENTS UNDERGOING STANDARD THERAPY S Chiranth, V Fougner, I Christensen, A Trip, T Christiansen, D Noroxe, ... NEURO-ONCOLOGY 26, V46-V46, 2024 | | 2024 |
| P27. 14. B OPTIMIZING GLIOBLASTOMA TRIAL DESIGN: A PROGNOSTIC MODEL HARNESSING REAL-WORLD DATA AND GENOMIC ALTERATIONS T Christiansen, V Fougner, SB Chiranth, RH Dahlrot, JK Petersen, ... Neuro-Oncology 26 (Supplement_5), v140-v140, 2024 | | 2024 |
| BIOM-39. GENETIC VARIANTS ASSOCIATED WITH DISTANT RECURRENCE IN GLIOBLASTOMA PATIENTS TREATED WITH STANDARD THERAPY V Fougner, S Chiranth, C Yde, D Nørøxe, I Christensen, B Hasselbalch, ... Neuro-Oncology 25 (Suppl 5), v13, 2023 | | 2023 |
| CTNI-32. IMPLEMENTING GENOMIC PROFILING AS STANDARD-OF-CARE FOR GLIOBLASTOMA PATIENTS V Fougner, T Urup, B Hasselbalch, H Poulsen, K Rohrberg, I Spanggard, ... Neuro-Oncology 25 (Suppl 5), v81, 2023 | | 2023 |
| Tracking tumor mutations in ctDNA through repetitive plasma samples in patients with newly diagnosed brain cancer DS Nørøxe, LB Ahlborn, V Fougner, T Urup, B Hasselbalch, CW Yde, ... Cancer Research 83 (7_Supplement), 1046-1046, 2023 | | 2023 |
| 81P Implementing genomic profiling as standard-of-care for glioblastoma patients VN Fougner, ADS Noeroexe, B Hasselbalch, T Urup, C Yde, L Belcaid, ... ESMO Open 8 (1), 2023 | | 2023 |
